Founded by Metsera backers, Sentivera emerges with $1.5B inflammatory disease deal

Having set Metsera on its journey to a $10 billion takeover, Arch Venture Partners and Population Health Partners have powered their new startup—Sentivera—to a licensing deal worth up to $1.5 billion.